You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

metastatic ocular melanoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Metastatic Malignant Tumor in the Brain Trial in

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +6 more
  • Ipilimumab
  • +4 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Dec 12, 2022

Metastatic Melanoma Trial in Burnsville (Aldesleukin: All Patients, Nivolumab: Cohort 1 (Cutaneous), Nivolumab: Cohort 2

Active, not recruiting
  • Metastatic Melanoma
  • Aldesleukin: All Patients
  • +3 more
  • Burnsville, Minnesota
    University of Minnesota Masonic Cancer Center
Feb 25, 2022

Cancer Metastatic to the Liver, Hepatocellular Carcinoma, Metastatic Melanoma Trial in United States (PV-10 (10% rose bengal

Recruiting
  • Cancer Metastatic to the Liver
  • +9 more
  • PV-10 (10% rose bengal disodium)
  • San Diego, California
  • +4 more
Mar 22, 2022

Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma Trial in Tampa (TBio-4101, Cyclophosphamide, Fludarabine)

Recruiting
  • Metastatic Melanoma
  • +9 more
  • TBio-4101
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 24, 2023

Melanoma, Ocular, Melanoma, Cutaneous, Metastatic Melanoma Trial in Ann Arbor (Ipilimumab, Nivolumab, Stereotactic Body

Not yet recruiting
  • Melanoma, Ocular
  • +4 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Mar 16, 2022

Uveal Melanoma Trial in Grand Rapids (Darovasertib)

Recruiting
  • Uveal Melanoma
  • Grand Rapids, Michigan
    The Cancer and Hematology Centers
Jun 14, 2023

Metastatic Uveal Melanoma Trial in Grand Rapids (IDE196, Crizotinib, Pembrolizumab)

Recruiting
  • Metastatic Uveal Melanoma
  • Grand Rapids, Michigan
    The Cancer and Hematology Centers
Aug 14, 2023

Tumor Skin, Metastatic Melanoma, Melanoma Trial in Orlando, Louisville (OBX-115)

Active, not recruiting
  • Tumor Skin
  • +2 more
  • OBX-115
  • Orlando, Florida
  • +1 more
Sep 28, 2023

Melanoma Trial (ABP 206, Nivolumab)

Not yet recruiting
  • Melanoma
  • (no location specified)
Sep 20, 2023

Metastatic Uveal Melanoma Trial in Tampa (ZIV-Aflibercept, Cemiplimab)

Recruiting
  • Metastatic Uveal Melanoma
  • Tampa, Florida
    Moffitt Cancer Center
Nov 2, 2023

Metastatic Uveal Melanoma Trial in Westmead (DYP688)

Recruiting
  • Metastatic Uveal Melanoma
  • Boston, Massachusetts
  • +8 more
Jan 31, 2023

Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

Not yet recruiting
  • Uveal Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 5, 2023

Uveal Melanoma Trial in Ribeirão Preto (Melphalan Injection, Plaque brachytherapy)

Enrolling by invitation
  • Uveal Melanoma
  • Melphalan Injection
  • Plaque brachytherapy
  • Ribeirão Preto, SP, Brazil
    Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto
May 29, 2023

Melanoma, Ocular Melanoma Trial in United States (Nivolumab, Ipilimumab)

Active, not recruiting
  • Melanoma
  • Ocular Melanoma
  • San Francisco, California
  • +5 more
Aug 31, 2022

Ocular Melanoma Trial in Sydney, Melbourne (Darovasertib)

Recruiting
  • Ocular Melanoma
  • Sydney, New South Wales, Australia
  • +1 more
May 3, 2022

Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers

Recruiting
  • Ocular Sebaceous Carcinoma
  • +5 more
  • Sentinel Lymph Node Biopsy
  • Roma, Rome, Italy
    Gustavo Savino
Apr 3, 2023

Immunotherapy in Patients With Metastatic Melanoma

Not yet recruiting
  • Metastatic Melanoma
  • data collection
  • (no location specified)
Nov 28, 2022

Uveal Melanoma, Melanoma, Metastatic Uveal Melanoma Trial in Harrison, New York (Lifileucel (LN-144))

Recruiting
  • Uveal Melanoma
  • +3 more
  • Lifileucel (LN-144)
  • Harrison, New York
  • +1 more
Nov 8, 2022

Healthcare Resource Utilization and Costs in Metastatic Melanoma

Terminated
  • Metastatic Melanoma
    • East Hanover, New Jersey
      Novartis Investigational Site
    Apr 27, 2023

    Metastatic Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Portland (GB1211, Pembrolizumab, Placebo)

    Not yet recruiting
    • Metastatic Melanoma
    • Head and Neck Squamous Cell Carcinoma
    • Portland, Oregon
      Providence Portland Medical Center
    Jun 19, 2023

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in

    Not yet recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +4 more
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Feb 28, 2023

    Baseline Metastases on Clinical Outcomes Among BRAF Positive

    Completed
    • BRAF Positive Metastatic Melanoma
      • East Hanover, New Jersey
        Novartis
      Aug 2, 2023

      Uveal Melanoma Trial in Nice, Paris (Supportive care visit with questionnaires, Oncological standard visit)

      Recruiting
      • Uveal Melanoma
      • Supportive care visit with questionnaires
      • Oncological standard visit
      • Nice, France
      • +1 more
      Jan 19, 2023

      Melanoma Trial in Beijing City, Fuzhou City, Zhejiang (Atezolizumab, Bevacizumab)

      Active, not recruiting
      • Melanoma
      • Beijing City, China
      • +2 more
      Dec 13, 2022

      Patients With Stage 0-IV Melanoma in Real Clinical Practice

      Recruiting
      • Melanoma
      • +7 more
      • surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines
      • Moscow, Russian Federation
        N.N. Blokhin Russian Cancer Research Center
      Jun 12, 2022